# Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy

> **NCT00542997** · PHASE3 · COMPLETED · sponsor: **CSL Behring** · enrollment: 51 (actual)

## Conditions studied

- Common Variable Immunodeficiency
- X-linked Agammaglobulinemia
- Autosomal Recessive Agammaglobulinemia

## Interventions

- **BIOLOGICAL:** Human Normal Immunoglobulin for Subcutaneous Administration (IGSC)

## Key facts

- **NCT ID:** NCT00542997
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2011-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00542997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00542997, "Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00542997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*